Tau-mediated neurodegeneration in Alzheimer's disease and related disorders - PubMed (original) (raw)
Review
doi: 10.1038/nrn2194.
Affiliations
- PMID: 17684513
- DOI: 10.1038/nrn2194
Review
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al. Nat Rev Neurosci. 2007 Sep.
Abstract
Advances in our understanding of the mechanisms of tau-mediated neurodegeneration in Alzheimer's disease (AD) and related tauopathies, which are characterized by prominent CNS accumulations of fibrillar tau inclusions, are rapidly moving this previously underexplored disease pathway to centre stage for disease-modifying drug discovery efforts. However, controversies abound concerning whether or not the deleterious effects of tau pathologies result from toxic gains-of-function by pathological tau or from critical losses of normal tau function in the disease state. This Review summarizes the most recent advances in our knowledge of the mechanisms of tau-mediated neurodegeneration to forge an integrated concept of those tau-linked disease processes that drive the onset and progression of AD and related tauopathies.
Similar articles
- The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M, Probst A. Tolnay M, et al. IUBMB Life. 2003 Jun;55(6):299-305. doi: 10.1080/1521654032000114348. IUBMB Life. 2003. PMID: 12938731 Review. - Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
Tolnay M, Sergeant N, Ghestem A, Chalbot S, De Vos RA, Jansen Steur EN, Probst A, Delacourte A. Tolnay M, et al. Acta Neuropathol. 2002 Oct;104(4):425-34. doi: 10.1007/s00401-002-0591-z. Epub 2002 Jul 26. Acta Neuropathol. 2002. PMID: 12200631 - Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
Zilka N, Korenova M, Novak M. Zilka N, et al. Acta Neuropathol. 2009 Jul;118(1):71-86. doi: 10.1007/s00401-009-0499-y. Epub 2009 Feb 24. Acta Neuropathol. 2009. PMID: 19238406 Review. - Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
Williams DR. Williams DR. Intern Med J. 2006 Oct;36(10):652-60. doi: 10.1111/j.1445-5994.2006.01153.x. Intern Med J. 2006. PMID: 16958643 Review. - Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.
Sorrentino G, Bonavita V. Sorrentino G, et al. Neurol Sci. 2007 Apr;28(2):63-71. doi: 10.1007/s10072-007-0789-x. Neurol Sci. 2007. PMID: 17464468 Review.
Cited by
- Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease.
Zota I, Chanoumidou K, Gravanis A, Charalampopoulos I. Zota I, et al. Front Cell Neurosci. 2024 Sep 2;18:1422130. doi: 10.3389/fncel.2024.1422130. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39285941 Free PMC article. Review. - Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.
Flieger J, Forma A, Flieger W, Flieger M, Gawlik PJ, Dzierżyński E, Maciejewski R, Teresiński G, Baj J. Flieger J, et al. Int J Mol Sci. 2024 Aug 18;25(16):8982. doi: 10.3390/ijms25168982. Int J Mol Sci. 2024. PMID: 39201668 Free PMC article. Review. - Exploring Novel GSK-3β Inhibitors for Anti-Neuroinflammatory and Neuroprotective Effects: Synthesis, Crystallography, Computational Analysis, and Biological Evaluation.
Góral I, Wichur T, Sługocka E, Grygier P, Głuch-Lutwin M, Mordyl B, Honkisz-Orzechowska E, Szałaj N, Godyń J, Panek D, Zaręba P, Sarka A, Żmudzki P, Latacz G, Pustelny K, Bucki A, Czarna A, Menezes F, Więckowska A. Góral I, et al. ACS Chem Neurosci. 2024 Sep 4;15(17):3181-3201. doi: 10.1021/acschemneuro.4c00365. Epub 2024 Aug 19. ACS Chem Neurosci. 2024. PMID: 39158934 Free PMC article. - Synthesis and Evaluation of Chloride-Substituted Ramalin Derivatives for Alzheimer's Disease Treatment.
Kim TK, Cho Y, Kim J, Lee J, Hong JM, Cho H, Kim JS, Lee Y, Kim KH, Kim IC, Han SJ, Oh H, Jo DG, Yim JH. Kim TK, et al. Molecules. 2024 Aug 5;29(15):3701. doi: 10.3390/molecules29153701. Molecules. 2024. PMID: 39125105 Free PMC article. - Characterization of Olive Oil Phenolic Extracts and Their Effects on the Aggregation of the Alzheimer's Amyloid-β Peptide and Tau.
Alaziqi B, Beckitt L, Townsend DJ, Morgan J, Price R, Maerivoet A, Madine J, Rochester D, Akien G, Middleton DA. Alaziqi B, et al. ACS Omega. 2024 Jul 17;9(30):32557-32578. doi: 10.1021/acsomega.4c01281. eCollection 2024 Jul 30. ACS Omega. 2024. PMID: 39100310 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- P01 AG09215/AG/NIA NIH HHS/United States
- P01 AG11542/AG/NIA NIH HHS/United States
- P01 AG14382/AG/NIA NIH HHS/United States
- P01 AG14449/AG/NIA NIH HHS/United States
- P01 AG17586/AG/NIA NIH HHS/United States
- P01 AG19724/AG/NIA NIH HHS/United States
- P01 NS-044233/NS/NINDS NIH HHS/United States
- P30 AG10124/AG/NIA NIH HHS/United States
- U01 AG24904/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical